Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Apr 21, 2026, 9:30 AM EST
YBGJ Revenue
In the year 2025, Yubo International Biotech had annual revenue of $12.35K with 255.99% growth. Yubo International Biotech had revenue of $12.35K in the quarter ending December 31, 2025.
Revenue
12.35K
Revenue Growth
+255.99%
P/S Ratio
137.96
Revenue / Employee
882.36
Employees
14
Market Cap
1.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.35K | 8.88K | 255.99% |
| Dec 31, 2024 | 3.47K | -601.21K | -99.43% |
| Dec 31, 2023 | 604.68K | 500.39K | 479.84% |
| Dec 31, 2022 | 104.28K | -1.14M | -91.62% |
| Dec 31, 2021 | 1.24M | -109.50K | -8.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| InnerScope Hearing Technologies | 14.51M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| American Scientific Resources | 1.05M |
| Standard Dental Labs | 236.23K |
| Hear AtLast Holdings | 93.20K |